The investment seeks high long-term total return through growth and current income... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ModerateAllocation
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PLFMX | 30.96 | 0.24 | +0.78% |
Principal Large Cap S&P 500 Index R3 | |||
FRBRX | 133.70 | 0.93 | +0.70% |
Franklin Biotechnology Discovery R6 | |||
NSCAX | 47.26 | 0.09 | +0.19% |
Nuveen Small-Cap Value Opps A | |||
PSIJX | 8.32 | -0.05 | -0.60% |
Principal SmallCap Growth I J | |||
MDOAX | 10.85 | -0.07 | -0.64% |
Morgan Stanley Developing Opportunity A |
A.I.dvisor indicates that over the last year, CVTRX has been closely correlated with CGNGX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVTRX jumps, then CGNGX could also see price increases.
Ticker / NAME | Correlation To CVTRX | 1D Price Change % | ||
---|---|---|---|---|
CVTRX | 100% | +0.57% | ||
CGNGX - CVTRX | 91% Closely correlated | +0.24% | ||
FGIIX - CVTRX | 91% Closely correlated | +0.29% | ||
GAIHX - CVTRX | 91% Closely correlated | +0.29% | ||
CGLGX - CVTRX | 91% Closely correlated | +0.29% | ||
FGGIX - CVTRX | 91% Closely correlated | +0.29% | ||
More |